Supporting the

Neuroendocrine Cancer Community

Galleri Test

Sep 13, 2021

Galleri test

At the end of last year, we shared with you, the news that an innovative blood test that may spot more than 50 types of cancer will be piloted by the NHS in a world-leading programme.

Today, the NHS will launch the world’s largest trial of this revolutionary new blood test – that can detect more than 50 types of cancer before symptoms appear.

The first people to take part will have blood samples taken at mobile testing clinics in retail parks and other convenient community locations.

The Galleri™ test checks for the earliest signs of cancer in the blood and the NHS-Galleri trial, the first of its kind, aims to recruit 140,000 volunteers in eight areas of England to see how well the test works in the NHS.

“It is an absolute priority to speed up the earlier detection of cancer to improve survival, and this trial has the potential to do just that across a range of types of cancer. We are very grateful to all the people who will be taking part in this important initiative, which could help us save many more lives in the future.”

Dame Cally Palmer, NHS National Director for Cancer

“We need to study the Galleri test carefully to find out whether it can significantly reduce the number of cancers diagnosed at a late stage. The test could be a game-changer for early cancer detection and we are excited to be leading this important research.

Cancer screening can find cancers earlier when they are more likely to be treated successfully, but not all types of screening work.”

Prof Peter Sasieni, Director of The Cancer Research UK 

& King’s College London Cancer Prevention Trials Unit

Further information can be found here.